Thalidomide approved.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000014:Abnormalities, Drug-Induced; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D007917:Leprostatic Agents; D013792:Thalidomide